Abstract
Drug discovery using advanced computational biology approaches is an emerging field in medical science and holds the promise towards identification of new drugs. The multidrug resistance in bacterial strains is a matter of serious concern specifically related to the pathogens associated with public health. Numerous strategies have been developed in the recent past to combat the MDR concerns. However, still due to upcoming new evolution mechanisms of bacterial strains, the issue has been addressed only to a limited extent. Pertaining to the limitations of molecular techniques, multiple in silico approaches are in trend with great advancements. This chapter is focused toward the description on several in silico techniques for drug discovery with an idea of target identification, namely, virtual screening, molecular docking, MD simulation, QSAR and pharmacophore modelling. In addition to multi-target identification, the structural genomics has also been illustrated which involves the three-dimensional structure predictions of proteins for better understanding to design drugs against MDR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abate, G., & Hoft, D. F. (2016). Immunotherapy for tuberculosis: Future prospects. Immuno Targets and therapy, 5, 37.
Agarwal, S., Chadha, D., & Mehrotra, R. (2015). Molecular modeling and spectroscopic studies of semustine binding with DNA and its comparison with lomustine–DNA adduct formation. Journal of Biomolecular Structure and Dynamics, 33(8), 1653–1668.
Ahmad, S., & Mokaddas, E. (2010). Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respiratory Medicine CME, 3(2), 51–61.
Alder, B. J., & Wainwright, T. E. (1959). Studies in molecular dynamics. I. General method. The Journal of Chemical Physics, 31(2), 459–466.
Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., & Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research, 25(17), 3389–3402.
Arabnia, H. R., & Tran, Q. N. (2015). Emerging trends in computational biology, bioinformatics, and systems biology: Algorithms and software tools. Morgan Kaufmann.
Bairoch, A., & Apweiler, R. (2000). The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Research, 28(1), 45–48.
Bansal, A. K. (2005). Bioinformatics in microbial biotechnology–a mini review. Microbial Cell Factories, 4(1), 19.
Bernal, P., Molina-Santiago, C., Daddaoua, A., & Llamas, M. A. (2013). Antibiotic adjuvants: Identification and clinical use. Microbial Biotechnology, 6(5), 445–449.
Bush, K., & Jacoby, G. A. (2010). Updated functional classification of β-lactamases. Antimicrobial Agents and Chemotherapy, 54(3), 969–976.
Carriço, J. A., Sabat, A. J., Friedrich, A. W., & Ramirez, M. (2013). Bioinformatics in bacterial molecular epidemiology and public health: Databases, tools and the next-generation sequencing revolution. Eurosurveillance, 18(4), 20382.
Case, D. A. (2002). Molecular dynamics and NMR spin relaxation in proteins. Accounts of Chemical Research, 35(6), 325–331.
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., et al. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26(16), 1668–1688.
Chakraborty, A. K. (2016). Multi-drug resistant genes in bacteria and 21st century problems associated with antibiotic therapy. Biotechnology Indian Journal, 12(12), 113.
Chen, H., Yu, R.-G., Yin, N.-N., & Zhou, J.-X. (2014). Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: A systematic review. Critical Care, 18(6), 675.
Chen, M.-Y., Lo, Y.-C., Chen, W.-C., Wang, K.-F., & Chan, P.-C. (2017). Recurrence after successful treatment of multidrug-resistant tuberculosis in Taiwan. PLoS One, 12(1), e0170980.
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012). Structure-based virtual screening for drug discovery: A problem-centric review. The AAPS Journal, 14(1), 133–141.
Clewell, D. B. (2014). Antibiotic resistance plasmids in bacteria. eLS.
Daggett, V. (2006). Protein folding− simulation. Chemical Reviews, 106(5), 1898–1916.
Deeb, O., & Goodarzi, M. (2012). In silico quantitative structure toxicity relationship of chemical compounds: Some case studies. Current Drug Safety, 7(4), 289–297.
Divakar, S., & Hariharan, S. (2015). 3D-QSAR studies on plasmodium falciparam proteins: A mini-review. Combinatorial Chemistry & High Throughput Screening, 18(2), 188–198.
Drawz, S. M., & Bonomo, R. A. (2010). Three decades of beta-lactamase inhibitors. Clin Microbiol Rev, 23, 160–201.
Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012). Biomolecular simulation: a computational microscope for molecular biology. Annual Review of Biophysics, 41, 429–452.
Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W., et al. (2003). A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24(16), 1999–2012.
Fang, C., & Xiao, Z. (2016). Receptor-based 3D-QSAR in drug design: Methods and applications in kinase studies. Current Topics in Medicinal Chemistry, 16(13), 1463–1477.
Foloppe, N., & MacKerell, A. D., Jr. (2000). All-atom empirical force field for nucleic acids: I. parameter optimization based on small molecule and condensed phase macromolecular target data. Journal of Computational Chemistry, 21(2), 86–104.
Forsberg, K. J., Reyes, A., Wang, B., Selleck, E. M., Sommer, M. O. A., & Dantas, G. (2012). The shared antibiotic resistome of soil bacteria and human pathogens. Science, 337(6098), 1107–1111.
Gibson, G., & Muse, S. V. (2002). A primer of genome science (Vol. 1). Sinauer Sunderland.
Gschwend, D. A., Good, A. C., & Kuntz, I. D. (1996). Molecular docking towards drug discovery. Journal of Molecular Recognition: An Interdisciplinary Journal, 9(2), 175–186.
Guedes, I. A., de Magalhães, C. S., & Dardenne, L. E. (2014). Receptor–ligand molecular docking. Biophysical Reviews, 6(1), 75–87.
Güner, O. F., & Bowen, J. P. (2014). Setting the record straight: The origin of the pharmacophore concept. Journal of Chemical Information and Modeling, 54(5), 1269–1283.
Gupta, C. L., Akhtar, S., & Bajpai, P. (2014). IN SILICO protein modeling: Possibilities and limitations. EXCLI, 13, 513–515.
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759.
Henry, B. D., Neill, D. R., Becker, K. A., Gore, S., Bricio-Moreno, L., Ziobro, R., et al. (2015). Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nature Biotechnology, 33(1), 81.
Hogeweg, P. (2011). The roots of bioinformatics in theoretical biology. PLoS Computational Biology, 7(3), e1002021.
Hopkins, A. L., & Groom, C. R. (2002). The druggable genome. Nature Reviews Drug Discovery, 1(9), 727.
Jacoby, G. A. (2009). AmpC β-lactamases. Clinical Microbiology Reviews, 22(1), 161–182.
Jiang, Z., & Zhou, Y. (2005). Using bioinformatics for drug target identification from the genome. American Journal of Pharmacogenomics, 5(6), 387–396.
Keen, E. C., & Adhya, S. L. (2015). Phage therapy: Current research and applications. Oxford: Oxford University Press.
Khedkar, S. A., Malde, A. K., Coutinho, E. C., & Srivastava, S. (2007). Pharmacophore modeling in drug discovery and development: An overview. Medicinal Chemistry, 3(2), 187–197.
Kho, A. N., Dexter, P. R., Warvel, J. S., Belsito, A. W., Commiskey, M., Wilson, S. J., et al. (2008). An effective computerized reminder for contact isolation of patients colonized or infected with resistant organisms. International Journal of Medical Informatics, 77(3), 194–198.
King, D. T., & Strynadka, N. C. J. (2013). Targeting metallo-β-lactamase enzymes in antibiotic resistance. Future Medicinal Chemistry, 5(11), 1243–1263.
Kramer, B., Metz, G., Rarey, M., & Lengauer, T. (1999). Part 1–Docking and scoring: Methods development-LIGAND DOCKING AND SCREENING WITH FLEXX. Medicinal Chemistry Research, 9(7–8), 463–478.
Kukol, A. (2008). Molecular modeling of proteins (Vol. 443). Springer.
Kwang, L. S. (2005). In silico high-throughput screening for ADME/Tox properties: PreADMET program. In Abstracts Conference Combinational Chemistry Japan (Vol. 21, pp. 22–28).
Lavecchia, A., & Di Giovanni, C. (2013). Virtual screening strategies in drug discovery: A critical review. Current Medicinal Chemistry, 20(23), 2839–2860.
Leach, A. R., & Gillet, V. J. (2007). An introduction to chemoinformatics.. Springer Science & Business Media.
Lengauer, T., & Rarey, M. (1996). Computational methods for biomolecular docking. Current Opinion in Structural Biology, 6(3), 402–406.
Lill, M. A. (2007). Multi-dimensional QSAR in drug discovery. Drug Discovery Today, 12(23–24), 1013–1017.
Lim, C., Takahashi, E., Hongsuwan, M., Wuthiekanun, V., Thamlikitkul, V., Hinjoy, S., et al. (2016). Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. eLife, 5.
Lynch, J. P., III, Clark, N. M., & Zhanel, G. G. (2013). Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). Expert Opinion on Pharmacotherapy, 14(2), 199–210.
Lyne, P. D. (2002). Structure-based virtual screening: An overview. Drug Discovery Today, 7(20), 1047–1055.
Mannhold, R., Kubinyi, H., & Folkers, G. (2006). High-throughput screening in drug discovery (Vol. 35). Wiley.
Mason, J. S., Morize, I., Menard, P. R., Cheney, D. L., Hulme, C., & Labaudiniere, R. F. (1999). New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. Journal of Medicinal Chemistry, 42(17), 3251–3264.
McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad, M. A., Baylay, A. J., et al. (2013). The comprehensive antibiotic resistance database. Antimicrobial Agents and Chemotherapy, 57(7), 3348–3357.
Medzhitov, R., Schneider, D. S., & Soares, M. P. (2012). Disease tolerance as a defense strategy. Science, 335(6071), 936–941.
Miller, M. B., & Bassler, B. L. (2001). Quorum sensing in bacteria. Annual Reviews in Microbiology, 55(1), 165–199.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
Nikaido, H. (2009). Multidrug resistance in bacteria. Annual Review of Biochemistry, 78, 119–146.
Nobili, S., Landini, I., Mazzei, T., & Mini, E. (2012). Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Medicinal Research Reviews, 32(6), 1220–1262.
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O’Brien, T. F., et al. (2005). Antimicrobial resistance in developing countries. Part I: Recent trends and current status. The Lancet Infectious Diseases, 5(8), 481–493.
Opal, S. M. (2016). Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. BioMed Central.
Ordonez, A. A., Weinstein, E. A., Bambarger, L. E., Saini, V., Chang, Y. S., DeMarco, V. P., et al. (2017). A systematic approach for developing bacteria-specific imaging tracers. Journal of Nuclear Medicine, 58(1), 144.
Palzkill, T. (2013). Metallo-β-lactamase structure and function. Annals of the New York Academy of Sciences, 1277(1), 91–104.
Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190.
Patodia, S., Bagaria, A., & Chopra, D. (2014). Molecular dynamics simulation of proteins: A brief overview. Journal of Physical Chemistry & Biophysics, 4(6), 1.
Paulsen, I. T. (2003). Multidrug efflux pumps and resistance: Regulation and evolution. Current Opinion in Microbiology, 6(5), 446–451.
Perumal, D., Lim, C. S., & Sakharkar, M. K. (2008). Microbial drug target identification using different computational approaches: Specific application to Pseudomonas aeruginosa. In Innovations in Information Technology, 2008. IIT 2008. International Conference on (pp. 135–139). IEEE.
Petrenko, R., & Meller, J. (2010). Molecular dynamics. eLS.
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., et al. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802.
Pinner, U. K. (2007). Contributors to volume 4. Comprehensive medicinal chemistry II, 2.
Pirhadi, S., Shiri, F., & Ghasemi, J. B. (2013). Methods and applications of structure based pharmacophores in drug discovery. Current Topics in Medicinal Chemistry, 13(9), 1036–1047.
Pittet, D., Safran, E., Harbarth, S., Borst, F., Copin, P., Rohner, P., et al. (1996). Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: Role of a hospital information system. Infection Control & Hospital Epidemiology, 17(8), 496–502.
Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., et al. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29(7), 845–854.
Qing, X., Lee, X. Y., De Raeymaecker, J., Tame, J. R. H., Zhang, K. Y. J., De Maeyer, M., & Voet, A. (2014). Pharmacophore modeling: Advances, limitations, and current utility in drug discovery.
Rasmussen, A. L., Okumura, A., Ferris, M. T., Green, R., Feldmann, F., Kelly, S. M., et al. (2014). Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science, 346(6212), 987–991.
Rohs, R., Bloch, I., Sklenar, H., & Shakked, Z. (2005). Molecular flexibility in ab initio drug docking to DNA: Binding-site and binding-mode transitions in all-atom Monte Carlo simulations. Nucleic Acids Research, 33(22), 7048–7057.
Roy, K., Kar, S., & Das, R. N. (2015). Understanding the basics of QSAR for applications in pharmaceutical sciences and risk assessment. London: Academic press.
Saeb, A. T. M., Abouelhoda, M., Selvaraju, M., Althawadi, S. I., Mutabagani, M., Adil, M., et al. (2017). The use of next-generation sequencing in the identification of a fastidious pathogen: A lesson from a clinical setup. Evolutionary Bioinformatics, 13, 1176934316686072.
Schiffelers, R. M., Storm, G., & Bakker-Woudenberg, I. A. J. M. (2001). Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models. International Journal of Pharmaceutics, 214(1–2), 103–105.
Schuler, L. D., Daura, X., & Van Gunsteren, W. F. (2001). An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase. Journal of Computational Chemistry, 22(11), 1205–1218.
Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24(5), 417–422.
Shenoi, S., Heysell, S., Moll, A., & Friedland, G. (2009). Multidrug-resistant and extensively drug-resistant tuberculosis: Consequences for the global HIV community. Current Opinion in Infectious Diseases, 22(1), 11.
Shin, W.-H., Zhu, X., Bures, M. G., & Kihara, D. (2015). Three-dimensional compound comparison methods and their application in drug discovery. Molecules, 20(7), 12841–12862.
Solt, I., Tomin, A., & Niesz, K. (n.d.). New approaches to virtual screening wed, 12/18/2013–3: 10pm.
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001). Bacteriophage therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649–659.
Tan, W., Mei, H., Chao, L., Liu, T., Pan, X., Shu, M., & Yang, L. (2013). Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors. Journal of Computer-Aided Molecular Design, 27(12), 1067–1073.
Todeschini, R., Consonni, V., & Gramatica, P. (n.d.). 4.05 Chemometrics in QSAR.
Unger, S. H., & Hansch, C. (1975). Quantitative models of steric effects. Progress in Physical Organic Chemistry, 12, 91–118.
Verma, J., Khedkar, V. M., & Coutinho, E. C. (2010). 3D-QSAR in drug design-a review. Current Topics in Medicinal Chemistry, 10(1), 95–115.
Wang, Y., Chiu, J.-F., & He, Q.-Y. (2009). Genomics and proteomics in drug design and discovery. In Pharmacology (pp. 561–573). Elsevier.
Wang, T., Wu, M.-B., Lin, J.-P., & Yang, L.-R. (2015). Quantitative structure–activity relationship: Promising advances in drug discovery platforms. Expert Opinion on Drug Discovery, 10(12), 1283–1300.
Worthington, R. J., & Melander, C. (2013). Combination approaches to combat multidrug-resistant bacteria. Trends in Biotechnology, 31(3), 177–184.
Wu, J.-H., Chen, Y.-C., Hsieh, S., Lin, H.-C., Chen, Y.-Y., Cheng, P.-H., et al. (2009). Real-time automated MDRO surveillance system. In BIOCOMP (pp. 764–769).
Yu, W., & MacKerell, A. D. (2017). Computer-aided drug design methods. In Antibiotics (pp. 85–106). Springer.
Zewdie, O., Mihret, A., Abebe, T., Kebede, A., Desta, K., Worku, A., & Ameni, G. (2018). Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia. New Microbes and New Infections, 21, 36–41.
Zimmermann, G. R., Lehar, J., & Keith, C. T. (2007). Multi-target therapeutics: When the whole is greater than the sum of the parts. Drug Discovery Today, 12(1–2), 34–42.
PhD Thesis:
Balaramnavar Vishalsinh Mohansinh (2015) Design and Synthesis of BMP Receptor agonist as anti osteoporotic and anti cancer agents and synthesis of some bioactive molecules. PhD thesis, Integral University, Lucknow, India.
Jani, Mitesh H (2015) Synthesis and evaluation of some novel heterocyclic compounds of biological interest by rational approach. PhD Thesis, Gujrat University, India.
Internet Page
Monoclonal antibodies (MABs). http://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/monoclonal-antibodies Accessed on 22 May 2018.
Multidrug-Resistant Organisms (MDROs): What Are They? https://portal.ct.gov/DPH/Infectious-Diseases/HAI/MultidrugResistant-Organisms-MDROs-What-Are-They Accessed 29 Apr 2018.
Polyclonal vs Monoclonal Antibodies. https://www.pacificimmunology.com/resources/antibody-introduction/polyclonal-vs-monoclonal-antibodies/ Accesssed on 22 May 2018.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saxena, G., Sharma, M., Fatima, F., Bajpai, P., Akhtar, S. (2019). In Silico Molecular Modelling: Key Technologies in the Drug Discovery Process to Combat Multidrug Resistance. In: Ahmad, I., Ahmad, S., Rumbaugh, K. (eds) Antibacterial Drug Discovery to Combat MDR. Springer, Singapore. https://doi.org/10.1007/978-981-13-9871-1_10
Download citation
DOI: https://doi.org/10.1007/978-981-13-9871-1_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9870-4
Online ISBN: 978-981-13-9871-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)